The Role of Isavuconazonium Sulphate for the Treatment of Blastomycosis: A Case Series and Antifungal Susceptibility.

Scolarici, Michael J; King, Coleton; Sterkel, Alana; Smith, Jeannina; Gauthier, Gregory; Saddler, Christopher

Scolarici, Michael J; King, Coleton; Sterkel, Alana; Smith, Jeannina; Gauthier, Gregory; Saddler, Christopher.

Afiliación

Scolarici MJ; Department of Medicine, Division of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA.
King C; Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA.
Sterkel A; Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA.
Smith J; Department of Medicine, Division of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA.
Gauthier G; Department of Medicine, Division of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA.
Saddler C; Department of Medicine, Division of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA.

Open Forum Infect Dis ; 9(7): ofac220, 2022 Jul.

Article en En | MEDLINE | ID: mdl-35821730

Palabras clave

Blastomyces dermatitidis; blastomycosis; isavuconazonium sulphate; susceptibility

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google